Senti Biosciences Holdings, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $-121.8M | $38.1M |
| Jun 2022 | — | $154.3M | $139.8M |
| Sep 2022 | — | $140.3M | $114.9M |
| Dec 2022 | — | $127.3M | $57.6M |
| Mar 2023 | — | $112.3M | $31.6M |
| Jun 2023 | — | $97.4M | $36.8M |
| Sep 2023 | — | $82.9M | $39.4M |
| Dec 2023 | — | $66.9M | $35.9M |
| Mar 2024 | — | $56.1M | $23.7M |
| Jun 2024 | — | $44.1M | $15.9M |
| Sep 2024 | — | $16.0M | $10.5M |
| Dec 2024 | — | $25.6M | $48.3M |
| Mar 2025 | — | $37.9M | $33.8M |
| Jun 2025 | — | $24.7M | $21.6M |
| Sep 2025 | — | $8.1M | $12.2M |
| Dec 2025 | — | $5.6M | $16.4M |
| Mar 2026 | — | $2.6M | $8.9M |
| Jun 2026 | — | $-3.4M | $6.5M |